ADMS - Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q2 2020 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS)
Q2 2020 Earnings Conference Call
August 7, 2020 4:30 PM
Company Participants
Peter Vozzo – Investor Relations
Neil McFarlane – Chief Executive Officer
Vijay Shreedhar – Chief Commercial Officer
Chris Prentiss – Chief Financial Officer
Conference Call Participants
Jason Butler – JMP
Presentation
Operator
Welcome to the Adamas Pharmaceuticals Second Quarter 2020 Financial Results Corporate Update Conference Call. [Operator Instructions]
I would now like to turn the call over to Peter Vozzo, Investor Relations representative for Adamas Pharmaceuticals. Please go ahead.
Peter Vozzo
Thank you, Gabriel, and good afternoon, everyone.
Before